Bringing the fundamentals into focus…
Back to Dianthus Therapeutics, Inc.
How Dianthus Therapeutics, Inc. stacks up
DNTH · against 1,216 other Healthcare companies
Growth
5/ 100
Near the bottom of its peers.
Ranked #1,151 of 1,217 · scores higher than 5% of peers
Bars: peers in each 10-point band of the growth score116 peers with a growth score of 0–9, including DNTH · Click a bar to see the companies
Why growth scores 5?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 97% of peers. Revenue growth: -67.3% vs peer median 6.1%
- slower revenue growth over three years: weaker than 96% of peers. 3-year revenue growth: -31.8% vs peer median 5.8%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = DNTH, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | DNTH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -67.3% | 6.1% | 3% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | -31.8% | 5.8% | 4% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around DNTH| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1,151 | 17.6B CNY (≈$2.5B) | 5 | 11 | |
| 1,151 | 1.7B USD | 5 | 23 | |
| 1,151 | 551M USD | 5 | 20 | |
| 1,151 | 4.8B USD | 5 | 27 | |
| 1,151 | 4.6B USD | 5 | 29 | |
| 1,151 | 952M USD | 5 | 3 | |
| 1,151 | 264M USD | 5 | 24 | |
| 1,151 | 91.2B USD | 5 | 18 | |
| 1,151 | 26.0B USD | 5 | 28 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score